FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045494596> ?p ?o ?g. }

• W2045494596 endingPage "288" @default.
• W2045494596 startingPage "278" @default.
• W2045494596 abstract "Background aims Cord blood (CB) transplants with co-infusion of third-party donor (TPD) mobilized hematopoietic stem cells (MHSC) have been shown to result in ‘bridge’ engraftment with prompt neutrophil recovery and high final rates of CB engraftment and full chimerism. This strategy overcomes the limitation posed by low cellularity of CB units for unrelated transplants in adults. Enhancement of adaptive immunity reconstitution without increasing risks of graft-versus-host disease (GvHD) is required to optimize results further. Our objectives were to evaluate co-infusion of mesenchymal stromal cells (MSC) from the same TPD regarding tolerance, CB engraftment and effects on acute (a)GvHD, both preventive and therapeutic. Methods Ex vivo-expanded bone marrow MSC were infused at the time of the transplant or the in case of refractory aGvHD. Results Nine patients received 1.04–2.15 × 106/kg (median 1.20) MSC immediately after CB and TPD MHSC. Neither immediate adverse side-effects nor significant differences regarding CB engraftment or aGvHD development were observed. Four patients developed grade II aGvHD, refractory to steroids in two. These reached complete remission after therapeutic infusions of MSC. Conclusions In recipients of ‘dual CB/TPD MHSC transplants’, MSC infusions were therapeutically effective for severe aGvHD but no significant differences in CB engraftment and incidence of severe aGvHD were observed following their prophylactic use. Although results of this study alone cannot conclusively determine the application of MSC in CB transplantation, we believe that, in this setting, the best use of MSC could be as pre-emptive treatment for aGvHD. Cord blood (CB) transplants with co-infusion of third-party donor (TPD) mobilized hematopoietic stem cells (MHSC) have been shown to result in ‘bridge’ engraftment with prompt neutrophil recovery and high final rates of CB engraftment and full chimerism. This strategy overcomes the limitation posed by low cellularity of CB units for unrelated transplants in adults. Enhancement of adaptive immunity reconstitution without increasing risks of graft-versus-host disease (GvHD) is required to optimize results further. Our objectives were to evaluate co-infusion of mesenchymal stromal cells (MSC) from the same TPD regarding tolerance, CB engraftment and effects on acute (a)GvHD, both preventive and therapeutic. Ex vivo-expanded bone marrow MSC were infused at the time of the transplant or the in case of refractory aGvHD. Nine patients received 1.04–2.15 × 106/kg (median 1.20) MSC immediately after CB and TPD MHSC. Neither immediate adverse side-effects nor significant differences regarding CB engraftment or aGvHD development were observed. Four patients developed grade II aGvHD, refractory to steroids in two. These reached complete remission after therapeutic infusions of MSC. In recipients of ‘dual CB/TPD MHSC transplants’, MSC infusions were therapeutically effective for severe aGvHD but no significant differences in CB engraftment and incidence of severe aGvHD were observed following their prophylactic use. Although results of this study alone cannot conclusively determine the application of MSC in CB transplantation, we believe that, in this setting, the best use of MSC could be as pre-emptive treatment for aGvHD." @default.
• W2045494596 created "2016-06-24" @default.
• W2045494596 creator A5000867442 @default.
• W2045494596 creator A5003420715 @default.
• W2045494596 creator A5015666382 @default.
• W2045494596 creator A5023580394 @default.
• W2045494596 creator A5025267881 @default.
• W2045494596 creator A5026068036 @default.
• W2045494596 creator A5032877228 @default.
• W2045494596 creator A5034820536 @default.
• W2045494596 creator A5038308800 @default.
• W2045494596 creator A5041478489 @default.
• W2045494596 creator A5046699862 @default.
• W2045494596 creator A5051896473 @default.
• W2045494596 creator A5061953751 @default.
• W2045494596 creator A5064624296 @default.
• W2045494596 creator A5069131774 @default.
• W2045494596 creator A5070242794 @default.
• W2045494596 creator A5077975123 @default.
• W2045494596 creator A5078004962 @default.
• W2045494596 creator A5083925677 @default.
• W2045494596 creator A5086408321 @default.
• W2045494596 date "2009-01-01" @default.
• W2045494596 modified "2023-10-17" @default.
• W2045494596 title "Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults" @default.
• W2045494596 cites W1883799289 @default.
• W2045494596 cites W1972171120 @default.
• W2045494596 cites W1973084689 @default.
• W2045494596 cites W1973617793 @default.
• W2045494596 cites W1975255476 @default.
• W2045494596 cites W1982408656 @default.
• W2045494596 cites W1983493560 @default.
• W2045494596 cites W2002218662 @default.
• W2045494596 cites W2012807631 @default.
• W2045494596 cites W2014974498 @default.
• W2045494596 cites W2031849770 @default.
• W2045494596 cites W2033284503 @default.
• W2045494596 cites W2035065708 @default.
• W2045494596 cites W2038270895 @default.
• W2045494596 cites W2042650904 @default.
• W2045494596 cites W2042896736 @default.
• W2045494596 cites W2071264317 @default.
• W2045494596 cites W2100764718 @default.
• W2045494596 cites W2121678953 @default.
• W2045494596 cites W2158670721 @default.
• W2045494596 cites W4253242430 @default.
• W2045494596 doi "https://doi.org/10.1080/14653240902807018" @default.
• W2045494596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19308773" @default.
• W2045494596 hasPublicationYear "2009" @default.
• W2045494596 type Work @default.
• W2045494596 sameAs 2045494596 @default.
• W2045494596 citedByCount "114" @default.
• W2045494596 countsByYear W20454945962012 @default.
• W2045494596 countsByYear W20454945962013 @default.
• W2045494596 countsByYear W20454945962014 @default.
• W2045494596 countsByYear W20454945962015 @default.
• W2045494596 countsByYear W20454945962016 @default.
• W2045494596 countsByYear W20454945962017 @default.
• W2045494596 countsByYear W20454945962018 @default.
• W2045494596 countsByYear W20454945962019 @default.
• W2045494596 countsByYear W20454945962020 @default.
• W2045494596 countsByYear W20454945962021 @default.
• W2045494596 countsByYear W20454945962022 @default.
• W2045494596 countsByYear W20454945962023 @default.
• W2045494596 crossrefType "journal-article" @default.
• W2045494596 hasAuthorship W2045494596A5000867442 @default.
• W2045494596 hasAuthorship W2045494596A5003420715 @default.
• W2045494596 hasAuthorship W2045494596A5015666382 @default.
• W2045494596 hasAuthorship W2045494596A5023580394 @default.
• W2045494596 hasAuthorship W2045494596A5025267881 @default.
• W2045494596 hasAuthorship W2045494596A5026068036 @default.
• W2045494596 hasAuthorship W2045494596A5032877228 @default.
• W2045494596 hasAuthorship W2045494596A5034820536 @default.
• W2045494596 hasAuthorship W2045494596A5038308800 @default.
• W2045494596 hasAuthorship W2045494596A5041478489 @default.
• W2045494596 hasAuthorship W2045494596A5046699862 @default.
• W2045494596 hasAuthorship W2045494596A5051896473 @default.
• W2045494596 hasAuthorship W2045494596A5061953751 @default.
• W2045494596 hasAuthorship W2045494596A5064624296 @default.
• W2045494596 hasAuthorship W2045494596A5069131774 @default.
• W2045494596 hasAuthorship W2045494596A5070242794 @default.
• W2045494596 hasAuthorship W2045494596A5077975123 @default.
• W2045494596 hasAuthorship W2045494596A5078004962 @default.
• W2045494596 hasAuthorship W2045494596A5083925677 @default.
• W2045494596 hasAuthorship W2045494596A5086408321 @default.
• W2045494596 hasConcept C109159458 @default.
• W2045494596 hasConcept C126322002 @default.
• W2045494596 hasConcept C142424586 @default.
• W2045494596 hasConcept C142724271 @default.
• W2045494596 hasConcept C197934379 @default.
• W2045494596 hasConcept C198826908 @default.
• W2045494596 hasConcept C203014093 @default.
• W2045494596 hasConcept C2779972918 @default.
• W2045494596 hasConcept C2780007613 @default.
• W2045494596 hasConcept C2780914630 @default.
• W2045494596 hasConcept C28328180 @default.
• W2045494596 hasConcept C2911091166 @default.
• W2045494596 hasConcept C54355233 @default.

• next